This study was conducted to detect C.sakazakii PIF and raw milk. Two hundred samples of PIF were taken from the infected hospital infants who used this type of milk and from the local markets in addition to 16 sample of raw milk were collected. The study is the first to report the isolation of C. sakazakii and Enterobacter spp. from raw milk in Iraq. The distribution of C.sakazakii and Enterobacter spp. among the presumptive isolates using Vitek-GN2 system gave 1/16(6.25%) isolates of C.sakazakii and 4/16 (25%) isolates of Enterobacter spp. Enterobacter spp. isolates include (E.cloacae ssp. cloacae and E.cloacae ssp. dissolvens, E.hormaechei, and E.ludwigii) that isolate from raw milk Differences in between percentages of each isolate persence were non-significant (P<0.05). The results of antibioticsusceptibility were determined using Vitek-2GN system; .sakazakii isolates showed 100% resistance to cefazolin and cefoxitin, but were highly sensitive to many antibiotics includes (Imipenem, Meropenem, Amikacin, Gentamicin, Tobramycin, Ciprofloxacin, Levofloxacin, Nitrofurantion, Trimethoprim sulfamethoxazole, Ampicillin, Ampicillin sulbactam, Pipercillin Tazobactam, Ceftazidime, Ceftriaxone, Cefepime Azetreonam and augmentin ). The present study did not determine C.sakazakii in all the samples of PIF that is available in the local markets.
